VAIDS
Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs
The mRNA SARS-CoV-2 vaccines were brought to market in response to the public health crises of Covid-19. The utilization of mRNA vaccines in the conte…
Highlights
- mRNA vaccines promote sustained synthesis of the SARS-CoV-2 spike protein.
- The spike protein is neurotoxic, and it impairs DNA repair mechanisms.
- Suppression of type I interferon responses results in impaired innate immunity.
- The mRNA vaccines potentially cause increased risk to infectious diseases and cancer.
- Codon optimization results in G-rich mRNA that has unpredictable complex effects.
The citations listed in this letter to the editor published in the Virology Journal show a mountain of evidence against these shots and makes a clear cut case for VAIDS.
Adverse effects of COVID-19 vaccines and measures to prevent them
Recently, The Lancet published a study on the effectiveness of COVID-19 vaccines and the waning of immunity with time. The study showed that immune function among vaccinated individuals 8 months after the administration of two doses of COVID-19 ...
www.ncbi.nlm.nih.gov
References
1. Nordström P, Ballin M, Nordström A. Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden. Lancet. 2022;399:814–823. doi: 10.1016/S0140-6736(22)00089-7. [PMC free article] [PubMed] [CrossRef] [Google Scholar]2. European Centre for Disease Prevention and Control. Interim public health considerations for the provision of additional COVID-19 vaccine doses. https://www.ecdc.europa.eu/en/publi...ealth-considerations-additional-vaccine-doses. Accessed 4 May 2022.
3. Mallapaty S. Fourth dose of COVID vaccine offers only slight boost against Omicron infection. Nature. 2022 doi: 10.1038/D41586-022-00486-9. [CrossRef] [Google Scholar]
4. Krienke C, Kolb L, Diken E, Streuber M, Kirchhoff S, Bukur T, et al. A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis. Science. 2021;371:145–153. doi: 10.1126/science.aay3638. [PubMed] [CrossRef] [Google Scholar]
5. Bansal S, Perincheri S, Fleming T, Poulson C, Tiffany B, Bremner RM, et al. Cutting edge: circulating exosomes with COVID spike protein are induced by BNT162b2 (Pfizer–BioNTech) vaccination prior to development of antibodies: a novel mechanism for immune activation by mRNA vaccines. J Immunol. 2021;207:2405–2410. doi: 10.4049/jimmunol.2100637. [PubMed] [CrossRef] [Google Scholar]
6. BNT162b2 Module 2.4. Nonclinical Overview. FDA-CBER-2021-4379-0000681 JW-v-HHS-prod-3-02418.pdf (judicialwatch.org) Access 6 May 2022.
7. Ndeupen S, Qin Z, Jacobsen S, Bouteau A, Estanbouli H, Igyártó BZ. The mRNA-LNP platform’s lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory. Science. 2021;24:103479. doi: 10.1016/j.isci.2021.103479. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
8. Yamamoto K. Risk of heparinoid use in cosmetics and moisturizers in individuals vaccinated against severe acute respiratory syndrome coronavirus. Thromb J. 2021 doi: 10.1186/s12959-021-00320-8. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
9. Lei Y, Zhang J, Schiavon CR, He M, Chen L, Shen H, et al. SARS-CoV-2 spike protein impairs endothelial function via downregulation of ACE 2. Circ Res. 2021;128:1323–1326. doi: 10.1161/CIRCRESAHA.121.318902. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
10. Liu Y, Soh WT, Kishikawa JI, Hirose M, Nakayama EE, Li S, et al. An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies. Cell. 2021;184:3452–66.e18. doi: 10.1016/j.cell.2021.05.032. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
11. Cho A, Muecksch F, Schaefer-Babajew D, Wang Z, Finkin S, Gaebler C, et al. Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination. Nature. 2021;600:517–522. doi: 10.1038/s41586-021-04060-7. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
12. Desai HD, Sharma K, Shah A, Patoliya J, Patil A, Hooshanginezhad Z, et al. Can SARS-CoV-2 vaccine increase the risk of reactivation of Varicella zoster. Systematic review. J Cosmet Dermatol. 2021;20:3350–3361. doi: 10.1111/jocd.14521. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
13. Barda N, Dagan N, Ben-Shlomo Y, Kepten E, Waxman J, Ohana R, et al. Safety of the BNT162b2 mRNA Covid-19 v in a nationwide setting. N Engl J Med. 2021;385:1078–1090. doi: 10.1056/NEJMOA2110475/SUPPL_FILE/NEJMOA2110475_DISCLOSURES.PDF. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
14. Seneff S, Nigh G, Kyriakopoulos AM, McCullough PA. Innate immune suppression by SARS-CoV-2 mRNA vaccinations: the role of G-quadruplexes, exosomes, and MicroRNAs. Food Chem Toxicol. 2022;164:113008. doi: 10.1016/J.FCT.2022.113008. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
15. Lee EJ, Cines DB, Gernsheimer T, Kessler C, Michel M, Tarantino MD, et al. Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination. Am J Hematol. 2021;96:534–537. doi: 10.1002/AJH.26132. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
16. Yamamoto K. Five important preventive measures against the exacerbation of coronavirus disease. Anaesthesiol Intensive Ther. 2021;53:358–359. doi: 10.5114/ait.2021.108581. [PubMed] [CrossRef] [Google Scholar]
17. Yamamoto K. Risk of propofol use for sedation in COVID-19 patient. Anaesthesiol Intensive Ther. 2020;52:354–355. doi: 10.5114/ait.2020.100477. [PubMed] [CrossRef] [Google Scholar]
18. Gundry SR. Observational findings of PULS cardiac test findings for inflammatory markers in patients receiving mRNA vaccines. Circulation. 2021;144(suppl_1):A10712–A10712. doi: 10.1161/circ.144.suppl_1.10712. [CrossRef] [Google Scholar]
19. Lai FTT, Li X, Peng K, Huang L, Ip P, Tong X, et al. Carditis After COVID-19 vaccination with a messenger RNA vaccine and an inactivated virus vaccine: a case-control study. Ann Intern Med. 2022;175:362–370. doi: 10.7326/M21-3700. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Last edited:
